Janux Therapeutics (JANX) Q2 2024 Earnings

7MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.5
-0.33
-0.17
0

Details

Expected EPS
-0.33125
Actual EPS
-0.3
Surprise EPS
0.03
Surprise Percent
+9.43%

Description

Janux Therapeutics (JANX) has reported earnings of -0.3 per share for Q2 2024.

0 Comments

Share your thoughts